Publications Tumour-reactive T-cell receptor identification, characterisation and off-target profiling: a preclinical evaluation of a TCR discovery platform Fields et. al BMJ Connections Oncology 2026 Jul 31, 2026 Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses Schmidt et al.Frontiers in Oncology 2025 Sep 8, 2025 PIPLOM: prediction of exogenous peptide loading on major histocompatibility complex class I molecules Schmidt et al.Bioinform Adv. 2025 Mar 3, 2025 In-depth analysis of human virus-specific CD8+ T cells delineates unique phenotypic signatures for T cell specificity prediction Schmidt et al.Cell Reports 2023 Oct 19, 2023 Single-cell analysis reveals clonally expanded tumor-associated CD57+ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade Fehlings, Kim et al. JITC 2022 Aug 18, 2022 NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome. Ishihara et al.JITC 2022 Jun 29, 2022 1 2 3 … 7
Tumour-reactive T-cell receptor identification, characterisation and off-target profiling: a preclinical evaluation of a TCR discovery platform Fields et. al BMJ Connections Oncology 2026 Jul 31, 2026
Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses Schmidt et al.Frontiers in Oncology 2025 Sep 8, 2025
PIPLOM: prediction of exogenous peptide loading on major histocompatibility complex class I molecules Schmidt et al.Bioinform Adv. 2025 Mar 3, 2025
In-depth analysis of human virus-specific CD8+ T cells delineates unique phenotypic signatures for T cell specificity prediction Schmidt et al.Cell Reports 2023 Oct 19, 2023
Single-cell analysis reveals clonally expanded tumor-associated CD57+ CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade Fehlings, Kim et al. JITC 2022 Aug 18, 2022
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome. Ishihara et al.JITC 2022 Jun 29, 2022